CABA

Cabaletta Bio Inc

NASDAQ: CABA · HEALTHCARE · BIOTECHNOLOGY

$2.62

-4.03% today

Updated 2026-07-29

Market cap

$443.51M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.77

Dividend yield

—

52W range

$1 – $4

Volume

4.6M

Market cap

$443.51M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.77

Dividend yield

—

52W range

$1 – $4

Volume

4.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.5

Quality

C+

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-5.8

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$13.38

+410.69%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.26x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -5.79 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-42.56M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-51.81M	$-67.67M	$-115.86M	$-167.86M	$-43.52M
EPS	—	—	—	—	$-1.77
Free cash flow	$-48.83M	$-54.24M	$-90.43M	$-132.31M	$-42.56M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-06-09	TOMASELLO, SHAWN	Buy	22,000	—
2026-06-09	SIMON, MARK	Buy	22,000	—
2026-06-09	HENRIQUES, RICHARD C JR	Buy	22,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CABA	$443.51M	24	4.3	3.0	5.0	5.5	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Cabaletta Bio Inc trades at $2.62. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -5.79, it sits in the distress.

Frequently asked questions

What is Cabaletta Bio Inc's stock price?

Cabaletta Bio Inc (CABA) trades at $2.62.

Is Cabaletta Bio Inc overvalued?

Cabaletta Bio Inc carries a Smart Value Score of 24/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Cabaletta Bio Inc (CABA)?

The 12-month analyst consensus target is $13.38, about 410.7% above the current $2.62. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Cabaletta Bio Inc's Altman Z-Score is -5.79, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-169.82%

Beta3.26

50D MA$3.18

200D MA$2.85

Shares out0.16B

Float0.14B

Short ratio—

Avg volume4.6M

Performance

1 week-3.68%

1 month-15.76%

3 months-12.37%

YTD+19.63%

1 year—

3 years—

5 years—

Compare

CABA vs LLY →CABA vs JNJ →CABA vs ABBV →Stock screener →